Showing 1 - 2 of 2
Persistent link: https://www.econbiz.de/10005508701
A new reimbursement scheme (RS) for glucose lowering therapies (GLT) was implemented in Sweden on March 1, 2010. Products on the market were retained, restricted, excluded or excluded for new courses in the new RS. The aim of this study was to compare utilization and costs of GLT for type 2...
Persistent link: https://www.econbiz.de/10011048419